Anna Kaplan

Anna Kaplan is a Senior Scientist II at Stablix, Inc., having previously held senior scientist roles at 858 Therapeutics and Gotham Therapeutics. Prior to their industry experience, Anna worked as a Postdoctoral Research Scientist at Columbia University, where Anna conducted experiments leading to important discoveries in Alzheimer's disease and cancer research. Anna also has experience as a biochemistry tutor and graduate teaching assistant. Anna holds a Ph.D. in Chemical Biology from Columbia University, along with a Master of Philosophy in Biological Sciences and a Bachelor of Science in Biology and Biochemistry from Brandeis University.